Literature DB >> 23630213

Consolidation chemotherapy for adults with AML in first remission: is there a best choice?

Richard M Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23630213     DOI： 10.1200/JCO.2013.48.6886

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single Centre.

Authors:  Jayachandran Perumal Kalaiyarasi; Prasanth Ganesan; Krishnarathinam Kannan; Trivadi S Ganesan; Venkatraman Radhakrishnan; Manikandan Dhanushkodi; S Krupashankar; Nikita Mehra; Tenali Gnana Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2018-10-01       Impact factor: 0.900

2.  Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.

Authors:  Nianxi Zhao; Sung-Nan Pei; Jianjun Qi; Zihua Zeng; Swaminathan P Iyer; Pei Lin; Ching-Hsuan Tung; Youli Zu
Journal:  Biomaterials       Date:  2015-07-15       Impact factor: 12.479

3.  Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia.

Authors:  Qingguo Liu; Hongye Gao; Junfan Li; Yimin Hu; Lihua Wu; Xin Zhao; Shangzhu Li
Journal:  EJHaem       Date:  2020-08-11

4.  Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study.

Authors:  Daniel Shepshelovich; Yonatan Edel; Hadar Goldvaser; Tal Dujovny; Ofir Wolach; Pia Raanani
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.